Encompass Health Corporation $EHC Stake Boosted by TD Private Client Wealth LLC

Key Points

• TD Private Client Wealth LLC increased its stake in Encompass Health by 165.1% in Q2, owning 8,125 shares worth approximately $996,000.
• Encompass Health recently reported $1.40 EPS for the last quarter, surpassing analysts’ expectations and signaling a 12.0% year-over-year revenue growth.
• The company announced a dividend increase from $0.17 to $0.19 per share, reflecting a commitment to returning value to shareholders.

TD Private Client Wealth LLC grew its stake in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 165.1% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,125 shares of the company's stock after acquiring an additional 5,060 shares during the period. TD Private Client Wealth LLC's holdings in Encompass Health were worth $996,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in EHC. Pinnacle Wealth Planning Services Inc. grew its stake in Encompass Health by 4.0% in the 1st quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock valued at $263,000 after buying an additional 99 shares during the last quarter. Caitong International Asset Management Co. Ltd raised its position in shares of Encompass Health by 19.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after buying an additional 115 shares during the last quarter. UMB Bank n.a. increased its stake in Encompass Health by 10.9% in the second quarter. UMB Bank n.a. now owns 1,187 shares of the company's stock valued at $146,000 after acquiring an additional 117 shares during the period. Arlington Trust Co LLC increased its stake in Encompass Health by 22.9% in the first quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares during the period. Finally, Exchange Traded Concepts LLC grew its stake in Encompass Health by 1.9% during the second quarter. Exchange Traded Concepts LLC now owns 8,095 shares of the company's stock worth $993,000 after buying an additional 152 shares during the last quarter. Institutional investors own 97.25% of the company's stock.

Encompass Health Stock Up 0.9%

Shares of EHC opened at $126.78 on Friday. Encompass Health Corporation has a one year low of $87.85 and a one year high of $127.86. The company has a market cap of $12.77 billion, a P/E ratio of 24.81, a P/E/G ratio of 2.20 and a beta of 0.92. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.06 and a quick ratio of 1.06. The firm has a 50 day simple moving average of $119.60 and a two-hundred day simple moving average of $114.55.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The company reported $1.40 EPS for the quarter, beating the consensus estimate of $1.20 by $0.20. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a net margin of 9.22% and a return on equity of 17.83%. The company's revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.11 earnings per share. Encompass Health has set its FY 2025 guidance at 5.120-5.340 EPS. Research analysts forecast that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, October 1st. This is a boost from Encompass Health's previous quarterly dividend of $0.17. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.6%. Encompass Health's payout ratio is presently 13.31%.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP Patrick William Tuer sold 1,020 shares of the business's stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $123.59, for a total transaction of $126,061.80. Following the sale, the executive vice president owned 18,846 shares of the company's stock, valued at approximately $2,329,177.14. The trade was a 5.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 2.00% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the company. Stephens raised Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target on the stock in a research note on Thursday, June 5th. UBS Group lifted their price target on shares of Encompass Health from $130.00 to $140.00 and gave the company a "buy" rating in a research note on Wednesday, August 6th. Truist Financial lifted their price target on shares of Encompass Health from $135.00 to $140.00 and gave the company a "buy" rating in a research note on Thursday, August 14th. Bank of America boosted their price objective on shares of Encompass Health from $145.00 to $160.00 and gave the stock a "buy" rating in a research note on Wednesday, September 10th. Finally, Wall Street Zen lowered shares of Encompass Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, June 6th. One analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of "Buy" and a consensus price target of $138.43.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.